Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Utility of Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease Double Blind Placebo Control Crossover Pilot Study

NCT02472210 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02472210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02472210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Utility of Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease Double Blind Placebo Control Crossover Pilot Study
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2014
Completion date
September 30, 2015
Enrollment
14 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease